Roche hands UK HIV drug brief to Aurora

Aurora, the start-up healthcare agency run by former Athena Medical PR board director Neil Crump and Fleishman-Hillard associate director Claire Eldridge, has inked a UK HIV contract with Roche.

The deal – Camden-based Aurora's first major ongoing contract – comes five months after the agency's launch (PRWeek, 9 Dec 2005).
The contract focuses on Fuzeon, the first of a new wave of anti-HIV drugs when it hit the market in 2003, and Roche's leading product of its type. The brief is also likely to cover Invirase.

Roche previously used Ketchum to handle UK PR for its HIV products. Ketchum said: 'We decided it was in the best interests of Fuzeon in the UK to be handled by a smaller agency.'

Roche continues to use Ketchum for global comms on HIV, a relationship that has existed for five years (PRWeek, 23 Feb 2001). Roche's UK links with Ketchum also continue in areas such as cancer.

Roche PR manager Greg Page said it was cranking up its Fuzeon comms following the appointment of a new brand marketing team.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in